Ed Roschak

CEO
NuVasive

Ed Roschak

CEO
NuVasive

Bio

Ed Roschak has served as  CEO of NuVasive Specialized Orthopedics, Inc. since February 2016.  Previously, he served as President and Chief Executive Officer, and as a member of the board of directors, of Ellipse Technologies, Inc. from September 2011 until NuVasive’s acquisition of Ellipse in February 2016.  From October 2010 to September 2011, Mr. Roschak served as Ellipse’s Chief Operating Officer.  Prior to Ellipse, Mr. Roschak was employed for nearly ten years by Broncus Technologies, Inc., medical device company focused on developing devices for the treatment of lung diseases, including serving as their Senior Vice President of Research and Development from January 2007 to February 2010.  During his time there, Broncus completed the spin-off of Asthmatx, a less-invasive catheter-based bronchial thermoplasty medical device company which was later acquired by Boston Scientific.  Prior to Broncus, Mr. Roschak served in several positions at Hewlett-Packard and Guidant following the acquisition of Origin Medsystems.  Mr. Roschak received a B.S. in mechanical engineering from the University of California, Santa Barbara and an M.B.A. from the University of Oregon.

All sessions by Ed Roschak